Kanchan Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KANCHAN HLTHCARE, and what generic and branded alternatives to KANCHAN HLTHCARE drugs are available?
KANCHAN HLTHCARE has five approved drugs.
Summary for Kanchan Hlthcare
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Kanchan Hlthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kanchan Hlthcare | OXCARBAZEPINE | oxcarbazepine | SUSPENSION;ORAL | 217782-001 | Feb 14, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Kanchan Hlthcare | LACOSAMIDE | lacosamide | TABLET;ORAL | 218014-001 | Apr 2, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Kanchan Hlthcare | CYCLOPHOSPHAMIDE | cyclophosphamide | CAPSULE;ORAL | 209872-001 | May 7, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
